Anthropic Withholds New AI Model From UK Testing Amid National Security Concerns

Mythos 5.1 was the first recent Anthropic model that the UK institute did not receive for pre-release testing; AISI had received advance access to OpenAI’s Astra model earlier in the month.
Anthropic says Mythos 5.1 is technically identical to its Fable 5.1 model but has less restrictive safeguards for vetted users working in cybersecurity and life sciences.
In life-sciences testing, Mythos 5.1 demonstrated an ability to design high-affinity molecular binders, which could support drug development and other biological applications.
A UK government insider said, “National security officials have concerns. They definitely didn’t test Mythos 5.1. There’s anxiety around it,” reflecting fears that the exclusion could become a recurring pattern.
Recent US export controls reportedly temporarily restricted access to Anthropic’s most advanced models for all foreign nationals, including foreign employees of US artificial-intelligence companies, adding to concerns about the model-access decision.
Anthropic refused to give the UK's AI Safety Institute early access to Claude Mythos 5.1, its newest high-powered model for cybersecurity and biology research. Cryptopolitan reports that UK officials fear President Trump's strict AI export rules pushed the decision. The move marks the first time the British institute was locked out of testing a major Anthropic model before public release.
British national-security officials are alarmed. BM Magazine notes that Mythos 5.1 is technically the same as Anthropic's Fable 5.1 but with weaker safety guardrails for vetted cybersecurity and life-sciences experts. The exclusion threatens the UK's ability to spot risks and maintain a seat at the global AI governance table.
Mythos 5.1 is built for experts in two sensitive fields: cybersecurity and drug discovery. Cryptopolitan reports that in life-sciences trials, the model showed it could design molecular binders with high precision — a capability that could speed up drug development. Anthropic has not disclosed whether the U.S. government explicitly blocked the UK access or merely encouraged restraint.
This snub is unprecedented. BM Magazine confirms that Mythos 5.1 is the first recent Anthropic model withheld from the UK's Artificial Intelligence Safety Institute for pre-release testing. Days earlier, the same UK institute had received early access to OpenAI's Astra model. The disparity signals possible U.S. policy divergence between companies.
Recent U.S. export restrictions temporarily barred all foreign nationals—even those employed by U.S. AI firms—from accessing Anthropic's most advanced models. WDC News 6 highlights that the UK sees this pattern as evidence Trump's protectionist policies are now reshaping private-sector decisions. A British government source told WDC News 6: "National security officials have concerns. They definitely didn't test Mythos 5.1. There's anxiety around it." The fear is that exclusions will become routine.
Britain argues that pre-release testing of advanced AI models is vital to assessing safety risks and security threats. Without access, the UK says it cannot fulfill its mission in global AI standards-setting. Guru Focus reports that the decision raises broader questions about whether U.S. labs are now aligning with U.S. protectionism. Anthropic says it is working with the U.S. government to expand access to additional partners, but has given no timeline.
Publishers
13
Articles
15
Reach
28